Connect with us

Health

Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – Devdiscourse

Read more about Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study on Devdiscourse

Published

on

Article feature image

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending